SCYNEXIS Gets Orphan Drug Status For SCY-078
May 13, 2016 at 10:03 AM EDT
SCYNEXIS, Inc. (NASDAQ: SCYX) said the FDA has granted orphan drug designation to its novel and structurally distinct glucan synthase ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.